Scribe Therapeutics Inc.

SCTX

SCTXScribe Therapeutics Inc. US flag

NASDAQ

21.19

USD

+0.46

- -

342.90MMarket Cap

Income Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Sales/Revenue/Turnover	27	51
+ Sales & Services Revenue	27	51
- Cost of Revenue	- -	- -
+ Cost of Goods & Services	- -	- -
Gross Profit	- -	- -
+ Other Operating Income	-27	-51
- Operating Expenses	70	77
+ Selling, General & Admin	13	16
+ Research & Development	57	61
+ Other Operating Expense	- -	- -
Operating Income (Loss)	-43	-26
- Non-Operating (Income) Loss	-5	-2
+ Interest Expense, Net	-4	-1
+ Interest Expense	2	2
- Interest Income	6	3
+ Other Non-Op (Income) Loss	-1	-2
Pretax Income	-38	-24
- Income Tax Expense (Benefit)	10	-2
- (Income) Loss from Affiliates	- -	- -
Income (Loss) from Cont Ops	-48	-22
- Net Extraordinary Losses (Gains)	- -	- -
+ Discontinued Operations	- -	- -
+ Extraord. & Accounting Changes	- -	- -
Income (Loss) Incl. MI	-48	-22
- Minority Interest	- -	- -
Net Income, GAAP	-48	-22
- Preferred Dividends	- -	- -
- Other Adjustments	- -	- -
Net Income Avail to Common, GAAP	-48	-22
EBIT	-43	-26
EBITDA	-40	-23
EBITDA Margin (%)	-145.7	-44.93
EBITA	-43	-26
Gross Margin (%)	100	100
Operating Margin (%)	-156.24	-50.94
Profit Margin (%)	-174.32	-42.62
Sales per Employee	- -	- -
Dividend per Share	- -	- -
Depreciation Expense	3	3
Basic Weighted Avg Shares	- -	- -
Basic EPS, GAAP	- -	- -
Basic EPS from Cont Ops	- -	- -
Diluted Weighted Avg Shares	- -	- -
Diluted EPS, GAAP	- -	- -
Diluted EPS from Cont Ops	- -	- -

Balance Sheet (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Current Assets	110	67
+ Cash, Cash Equivalents & STI	105	58
+ Cash & Cash Equivalents	13	13
+ ST Investments	93	45
+ Accounts & Notes Receiv	4	7
+ Accounts Receivable, Net	- -	- -
+ Notes Receivable, Net	- -	- -
+ Loans Receivable, Net	- -	- -
+ Other Receivable, Net	4	7
+ Inventories	- -	- -
+ Raw Materials	- -	- -
+ Work In Process	- -	- -
+ Finished Goods	- -	- -
+ Inventory Adjustments	- -	- -
+ Other Inventory	- -	- -
+ Other ST Assets	2	2
+ Misc ST Assets	- -	- -
+ Prepaid Expenses	- -	- -
+ ST Derivative & Hedging Assets	- -	- -
+ ST Assets Held-for-Sale	- -	- -
+ ST Deferred Tax Assets	- -	- -
Total Noncurrent Assets	18	11
+ Property, Plant & Equip, Net	13	10
+ Property, Plant & Equip	21	21
- Accumulated Depreciation	8	11
+ LT Investments & Receivables	- -	- -
+ LT Investments	- -	- -
+ LT Receivables	- -	- -
+ Other LT Assets	4	1
+ Total Intangible Assets	- -	- -
+ Goodwill	- -	- -
+ Other Intangible Assets	- -	- -
+ LT Deferred Tax Assets	- -	- -
+ LT Derivative & Hedging Assets	- -	- -
+ Misc LT Assets	4	1
Total Assets	128	78
+ Payables & Accruals	7	7
+ Accounts Payable	4	5
+ Accrued Taxes	1	- -
+ Interest & Dividends Payable	- -	- -
+ Other Payables & Accruals	2	2
+ ST Debt	1	37
+ ST Borrowings	- -	35
+ ST Finance Leases	1	1
+ Other ST Liabilities	27	26
+ Deferred Revenue	23	21
+ Derivatives & Hedging	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Misc ST Liabilities	4	4
Total Current Liabilities	35	69
+ LT Debt	41	5
+ LT Borrowings	34	- -
+ LT Finance Leases	6	5
+ Other LT Liabilities	178	148
+ Accrued Liabilities	49	20
+ Pension Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Derivatives & Hedging	- -	- -
+ Misc LT Liabilities	129	128
Total Noncurrent Liabilities	219	153
Total Liabilities	254	222
+ Preferred Equity and Hybrid Capital	- -	- -
+ Share Capital & APIC	10	14
+ Common Stock	- -	- -
+ Additional Paid in Capital	10	14
- Treasury Stock	- -	- -
+ Retained Earnings	-136	-158
+ Other Equity	- -	- -
Equity Before Minority Interest	-126	-143
+ Minority/Non Controlling Interest	- -	- -
Total Equity	-126	-143
Total Liabilities & Equity	128	78
Shares Outstanding	- -	- -
Number of Employees	- -	- -
Capital Leases - Total	7	6
Net Debt	22	23
Net Debt to Equity	-17.38	-15.72
Tangible Common Equity Ratio	-98.35	-183.36
Current Ratio	3.15	0.97
Cash Conversion Cycle	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

+ Net Income	-48	-22
+ Depreciation & Amortization	3	3
+ Non-Cash Items	5	10
+ Stock-Based Compensation	3	4
+ Deferred Income Taxes	- -	- -
+ Asset Impairment Charge	- -	- -
+ Other Non-Cash Adj	2	6
+ Chg in Non-Cash Work Cap	-5	-36
+ (Inc) Dec in Accts Receiv	-1	-4
+ (Inc) Dec in Inventories	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -
+ Inc (Dec) in Accts Payable	-4	1
+ Inc (Dec) in Other	1	-34
+ Net Cash From Disc Ops	- -	- -
Cash from Operating Activities	-45	-45
+ Change in Fixed & Intang	- -	- -
+ Disp in Fixed & Intang	- -	- -
+ Disp of Fixed Prod Assets	- -	- -
+ Disp of Intangible Assets	- -	- -
+ Acq of Fixed & Intang	-1	-1
+ Acq of Fixed Prod Assets	-1	-1
+ Acq of Intangible Assets	- -	- -
+ Cash (Repurchase) of Equity	- -	- -
+ Increase in Capital Stock	- -	- -
+ Decrease in Capital Stock	- -	- -
+ Net Change in LT Investment	14	47
+ Dec in LT Investment	138	105
+ Inc in LT Investment	-124	-58
+ Net Cash From Acq & Div	- -	- -
+ Cash from Divestitures	- -	- -
+ Cash for Acq of Subs	- -	- -
+ Cash for JVs	- -	- -
+ Other Investing Activities	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Investing Activities	13	45
+ Dividends Paid	- -	- -
+ Net Cash From Debt	- -	- -
+ Cash From Debt	- -	- -
+ Repayments of Debt	- -	- -
+ Other Financing Activities	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Financing Activities	- -	- -
Effect of Foreign Exchange Rates	- -	- -
Net Changes in Cash	-32	- -
EBITDA	-40	-23
EBITDA Margin (%)	-145.7	-44.93
Free Cash Flow	-47	-46
Net Cash Paid for Acquisitions	- -	- -
Free Cash Flow to Firm	- -	- -
Free Cash Flow to Equity	- -	-46
Free Cash Flow per Basic Share	- -	- -
Price/Free Cash Flow	- -	- -
Cash Flow to Net Income	0.95	2.07
Capital Expenditures	-1	-1